An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-κB Activation for Disease-Inducible Gene Transfer.

Stimulation of resident cells by NF-κB activating cytokines is a central element of inflammatory and degenerative disorders of the central nervous system (CNS). This disease-mediated NF-κB activation could be used to drive transgene expression selectively in affected cells, using adeno-associated virus (AAV)-mediated gene transfer. We have constructed a series of AAV vectors expressing GFP under the control of different promoters including NF-κB -responsive elements. As an initial screen, the vectors were tested in vitro in HEK-293T cells treated with TNF-α. The best profile of GFP induction was obtained with a promoter containing two blocks of four NF-κB -responsive sequences from the human JCV neurotropic polyoma virus promoter, fused to a new tight minimal CMV promoter, optimally distant from each other. A therapeutical gene, glial cell line-derived neurotrophic factor (GDNF) cDNA under the control of serotype 1-encapsidated NF-κB -responsive AAV vector (AAV-NF) was protective in senescent cultures of mouse cortical neurons. AAV-NF was then evaluated in vivo in the kainic acid (KA)-induced status epilepticus rat model for temporal lobe epilepsy, a major neurological disorder with a central pathophysiological role for NF-κB activation. We demonstrate that AAV-NF, injected in the hippocampus, responded to disease induction by mediating GFP expression, preferentially in CA1 and CA3 neurons and astrocytes, specifically in regions where inflammatory markers were also induced. Altogether, these data demonstrate the feasibility to use disease-activated transcription factor-responsive elements in order to drive transgene expression specifically in affected cells in inflammatory CNS disorders using AAV-mediated gene transfer.

Rapid transgene expression in multiple precursor cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors.

Abstract The adult rat brain subventricular zone (SVZ) contains proliferative precursors that migrate to the olfactory bulb (OB) and differentiate into mature neurons. Recruitment of precursors constitutes a potential avenue for brain repair. We have investigated the kinetics and cellular specificity of transgene expression mediated by AAV2/1 vectors (i.e., adeno-associated virus type 2 pseudotyped with AAV1 capsid) in the SVZ. Self-complementary (sc) and single-stranded (ss) AAV2/1 vectors mediated efficient GFP expression, respectively, at 17 and 24 hr postinjection. Transgene expression was efficient in all the rapidly proliferating cells types, that is, Mash1(+) precursors (30% of the GFP(+) cells), Dlx2(+) neuronal progenitors (55%), Olig2(+) oligodendrocyte progenitors (35%), and doublecortin-positive (Dcx(+)) migrating cells (40%), but not in the slowly proliferating glial fibrillary acidic protein-positive (GFAP(+)) neural stem cell pool (5%). Because cell cycle arrest by wild-type and recombinant AAV has been described in primary cultures, we examined SVZ proliferative activity after vector injection. Indeed, cell proliferation was reduced immediately after vector injection but was normal after 1 month. In contrast, migration and differentiation of GFP(+) precursors were unaltered. Indeed, the proportion of Dcx(+) cells was similar in the injected and contralateral hemispheres. Furthermore, 1 month after vector injection into the SVZ, GFP(+) cells, found, as expected, in the OB granular cell layer, were mature GABAergic neurons. In conclusion, the rapid and efficient transgene expression in SVZ neural precursors mediated by scAAV2/1 vectors underlines their potential usefulness for brain repair via recruitment of immature cells. The observed transient precursor proliferation inhibition, not affecting their migration and differentiation, will likely not compromise this strategy.

An adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer.

Stimulation of resident cells by NF-κB activating cytokines is a central element of inflammatory and degenerative disorders of the central nervous system (CNS). This disease-mediated NF-κB activation could be used to drive transgene expression selectively in affected cells, using adeno-associated virus (AAV)-mediated gene transfer. We have constructed a series of AAV vectors expressing GFP under the control of different promoters including NF-κB -responsive elements. As an initial screen, the vectors were tested in vitro in HEK-293T cells treated with TNF-α. The best profile of GFP induction was obtained with a promoter containing two blocks of four NF-κB -responsive sequences from the human JCV neurotropic polyoma virus promoter, fused to a new tight minimal CMV promoter, optimally distant from each other. A therapeutical gene, glial cell line-derived neurotrophic factor (GDNF) cDNA under the control of serotype 1-encapsidated NF-κB -responsive AAV vector (AAV-NF) was protective in senescent cultures of mouse cortical neurons. AAV-NF was then evaluated in vivo in the kainic acid (KA)-induced status epilepticus rat model for temporal lobe epilepsy, a major neurological disorder with a central pathophysiological role for NF-κB activation. We demonstrate that AAV-NF, injected in the hippocampus, responded to disease induction by mediating GFP expression, preferentially in CA1 and CA3 neurons and astrocytes, specifically in regions where inflammatory markers were also induced. Altogether, these data demonstrate the feasibility to use disease-activated transcription factor-responsive elements in order to drive transgene expression specifically in affected cells in inflammatory CNS disorders using AAV-mediated gene transfer.

Macular dystrophy associated with the mitochondrial DNA A3243G mutation: pericentral pigment deposits or atrophy? Report of two cases and review of the literature.

BACKGROUND: The A3243G point mutation in mitochondrial DNA (mtDNA) is associated with MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) and MIDD syndromes (maternally inherited diabetes and deafness). Both MELAS and MIDD patients can present with visual symptoms due to a retinopathy, sometimes before the genetic diagnosis is made. CASE PRESENTATION: Patient 1: 46 year-old woman with diabetes mellitus and hearing loss was referred for an unspecified maculopathy detected during screening evaluation for diabetic retinopathy. Visual acuity was 20/20 in both eyes. Fundus examination showed bilateral macular and peripapillary hyperpigmented/depigmented areas.Patient 2: 45 year-old woman was referred for recent vision loss in her left eye. History was remarkable for chronic fatigue, migraine and diffuse muscular pain. Visual acuity was 20/20 in her right eye and 20/30 in her left eye. Fundus exhibited several nummular perifoveal islands of retinal pigment epithelium atrophy and adjacent pale deposits in both eyes.Retinal anatomy was investigated with autofluorescence, retinal angiography and optical coherence tomography. Retinal function was assessed with automated static perimetry, full-field and multifocal electroretinography and electro-oculography. Genetic testing of mtDNA identified a point mutation at the locus 3243. CONCLUSION: Observation of RPE abnormalities in the context of suggestive systemic findings should prompt mtDNA testing.

Um estudo clínico, bioquímico, histoquímico e genético-molecular de pacientes com doenças do DNA mitocondrial

Introdução: As doenças mitocondriais apresentam características heterogêneas devido à própria natureza e função da mitocôndria, que possui o seu próprio DNA (mtDNA). A disfunção mitocondrial pode afetar um único órgão ou ser uma doença multissistêmica, de manifestação na infância ou na vida adulta, podendo ter um padrão de herança materna ou mendeliana. O diagnóstico é complexo e requer uma investigação criteriosa, passo-a-passo, com atenção a história clínica, exames laboratoriais, neuroimagem e, muitas vezes, a biópsia muscular para análise histoquímica, bioquímica e genética. A análise molecular é fundamental na definição do diagnóstico e os protocolos propostos até o momento são, geralmente, direcionados para um grupo de pacientes com características clínicas homogêneas. Objetivos: os objetivos deste trabalho foram: a) propor um protocolo combinando dados clínicos e laboratoriais para indicar a melhor forma de investigação molecular de pacientes com suspeita clínica de doença do DNA mitocondrial, b) Comparar os achados clínicos e laboratoriais nos pacientes com e sem mutação no mtDNA, c) avaliar quais são os fatores clínicos preditivos de mutação no mtDNA que podem ser utilizados como sinalizadores para o médico decidir quando deve ser realizado um procedimento diagnóstico invasivo e de alto custo, c) estimar a proporção de mtDNA mutado, através da técnica PCR em tempo real em um grupo de pacientes com deleção, correlacionando com a idade de início dos sintomas e gravidade de manifestações clínicas, d) relatar achados de RNM com espectroscopia por emissão de prótons em pacientes com deleção no mtDNA. Pacientes, material e métodos: Foram selecionados, no ambulatório de doenças mitocondriais do HCPA, 43 pacientes com suspeita clínica de doença mitocondrial. Esse pacientes foram submetidos à análise, por etapas, de 5 mutações de ponto no mtDNA de leucócitos, de deleção no mtDNA de músculo e ao sequenciamento do tRNAleu e tRNAlys. Os pacientes com resultados positivos e negativos para mutações do mtDNA foram então comparados em relação às suas características clínicas e laboratoriais. Foram selecionados 11 pacientes para a determinação da percentagem relativa de deleção do mtDNA no tecido muscular e 3 pacientes para a descrição da RNM com espectroscopia. Resultados – Foram encontradas mutações no mtDNA em 17 pacientes (39.9%) distribuídas da seguinte forma: 4 pacientes com MELAS (A3243G), 1 paciente com síndrome de Leigh (T8993C) e 12 pacientes com deleções no mtDNA. As características significativamente mais freqüentes no grupo de pacientes com mutação no mtDNA comparados com os demais foram: miopatia (p=0,032), retinopatia pigmentar (p=0,007), oftalmoplegia e ptose (p=0,002), baixa estatura (p=0,04), hipotrofismo (p=0,033) e acidose lática (p=0,006). A quantificação do mtDNA pela técnica de PCR em tempo real foi realizada em 11 amostras de músculo de pacientes com deleção no mtDNA e com diferentes manifestações clínicas. Não houve correlação entre a percentagem relativa de deleção no mtDNA com os fenótipos clínicos (PEO, KSS e encefalomiopatia associado à doença multissistêmica), bem como com a idade de início das manifestações clínicas. A RNM com espectroscopia por emissão de prótons realizada em três pacientes com deleção no mtDNA associada a um quadro clínico não clássico mostrou achados distintos para cada paciente, sendo comum a todos as lesões cerebrais e a presença do pico invertido de lactato. Conclusões - A criteriosa seleção clínica e laboratorial se mostrou apropriada e o protocolo empregado se mostrou eficiente, uma vez que a mutação no mtDNA pode ser detectada em 17 dos 43 pacientes com suspeita de doença mitocondrial. Os pacientes positivos para deleção no mtDNA apresentaram algumas características clínicas preditivas para doença do mtDNA, o que pode ser importante na indicação de um procedimento invasivo (biópsia muscular) e de alto custo. A técnica e PCR em tempo real pode ser utilizado para quantificar a percentagem relativa de mtDNA deletado, porém para o diagnóstico das deleções, essa técnica deve ser realizada de forma complementar à técnica tradicional (Southern blot). O número amostral ainda é pequeno para correlacionar a quantidade relativa de mtDNA deletado com as síndromes mitocondriais clássicas e não clássicas. A RNM com espectroscopia por emissão de prótons, por possibilitar a detecção do lactato cerebral, parece ter utilidade na avaliação clínica de pacientes com suspeita clínica de doença mitocondrial, mesmo quando o quadro não é clássico.

Cetacean records along São Paulo state coast, Southeastern Brazil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

A note on the unprecedented strandings of 56 deep-diving whales along the UK and Irish coast

In the first seven months of 2008, eighteen Cuvier’s beaked whales (Ziphius cavirostris), four Sowerby’s beaked whales (Mesoplodon bidens), five unidentified beaked whales and twenty-nine long-finned pilot whales (Globicephala melas) were reported stranded in the UK and Ireland. Decomposition of those animals investigated puts the predicted time of death at mid-January. Concerns that an unusual mortality event had taken place prompted further investigations. Most carcasses were too decomposed for necropsy. A summary of findings is presented here. Although the initial stranding of five Cuvier’s beaked whales in Scotland shared some similarities with atypical mass stranding events linked in time and space to mid-frequency naval sonars, there were two important differences with the remaining strandings during this period. First, the geographical range of the event was very wide and second, the strandings occurred over a prolonged period of several months. Both of these factors could be related to the fact that the mortalities occurred offshore and the carcasses drifted ashore. The cause(s) of this high number of strandings of mixed offshore cetacean species during this period remain undetermined.

Characterization of extraintestinal pathogenic Escherichia coli isolated from captive wild felids with bacteremia

Diseases caused by extraintestinal pathogenic Escherichia coli (ExPEC) in wild felids are rarely reported. Although urinary tract infections are infrequently reported in domestic cats, such infections when present are commonly caused by ExPEC. The present work characterized ExPEC strains isolated from 2 adult felines, a snow leopard (Panthera uncia) and a black leopard (Panthera pardus melas), that died from secondary bacteremia associated with urinary tract infections. Isolates from both animals were classified into the B2 phylogenetic group and expressed virulence genotypes that allowed them to cause severe disease. In addition, strains from the black leopard showed multidrug resistance.

Estudio de las patologías y causas de muerte de cetáceos varados en el litoral de la provincia de Cádiz (2001-2004)

Programa de doctorado: Sanidad animal

(Table 3) Concentrations of polybrominated diphenyl ether and congeners in blubber samples from whales, seals and porpoises between 1986-2009

A selection of PBDE congeners was analyzed in pooled blubber samples of pilot whale (Globicephala melas), ringed seal (Phoca hispida), minke whale (Balaenoptera acutorostrata), fin whale (Balaenoptera physalus), harbor porpoise (Phocoena phocoena), hooded seal (Cystophora cristata) and Atlantic white-sided dolphin (Lagenorhynchus acutus), covering a time period of more than 20 years (1986-2009). The analytes were extracted and cleaned-up using open column extraction and multi-layer silica gel column chromatography, and the analysis was performed on a GC-MS system operating in the NCI mode. The highest PBDE levels were found in the toothed whale species pilot whale and white-sided dolphin, and the lowest levels in fin whales and ringed seals. One-sided analyses of variance (ANOVA) followed by Tukey comparisons of means were applied to test for differences between years and sampling areas. Due to inter-year sampling variability, only general comparisons of PBDE concentrations between different sampling areas could be made. Differences in PBDE concentrations between three sampling periods, from 1986 to 2007, were evaluated in samples of pilot whales, ringed seals, white-sided dolphins and hooded seals. The highest PBDE levels were found in samples from the late 1990s or beginning of 2000, possibly reflecting the increase in the global production of technical PBDE mixtures in the 1990s. The levels of BDE #153 and #154 increased relative to the total PBDE concentration in some of the species in recent years, which may indicate an increased relative exposure to higher brominated congeners. In order to assess the effect of measures taken in legally binding international agreements, it is important to continuously monitor POPs such as PBDEs in sub-Arctic and Arctic environments.

(Table 2) Concentrations of polychlorinated naphthalene congeners in blubber samples from whales, seals and porpoises between 1986-2009

A selection of PCN congeners was analyzed in pooled blubber samples of pilot whale (Globicephala melas), ringed seal (Phoca hispida), minke whale (Balaenoptera acutorostrata), fin whale (Balaenoptera physalus), harbour porpoise (Phocoena phocoena), hooded seal (Cystophora cristata) and Atlantic whitesided dolphin (Lagenorhynchus acutus), covering a time period of more than 20 years (1986-2009). A large geographical area of the North Atlantic and Arctic areas was covered. PCN congeners 48, 52, 53, 66 and 69 were found in the blubber samples between 0.03 and 5.9 ng/g lw. Also PCBs were analyzed in minke whales and fin whales from Iceland and the total PCN content accounted for 0.2% or less of the total non-planar PCB content. No statistically significant trend in contaminant levels could be established for the studied areas. However, in all species except minke whales caught off Norway the lowest Sum PCN concentrations were found in samples from the latest sampling period.

(Table 2) Polybrominated diphenyl ether concentration in blubber samples from whales, seals and porpoises between 1986-2009

A selection of MeO-BDE and BDE congeners were analyzed in pooled blubber samples of pilot whale (Globicephala melas), ringed seal (Phoca hispida), minke whale (Balaenoptera acutorostrata), fin whale (Balaenoptera physalus), harbor porpoise (Phocoena phocoena), hooded seal (Cystophora cristata), and Atlantic white-sided dolphin (Lagenorhynchus acutus), covering a time period of more than 20 years (1986-2009). The analytes were extracted and cleaned-up using open column extraction and multi-layer silica gel column chromatography. The analysis was performed using both low resolution and high resolution GC-MS. MeO-PBDE concentrations relative to total PBDE concentrations varied greatly between sampling periods and species. The highest MeO-PBDE levels were found in the toothed whale species pilot whale and white-sided dolphin, often exceeding the concentration of the most abundant PBDE, BDE-47. The lowest MeO-PBDE levels were found in fin whales and ringed seals. The main MeO-BDE congeners were 6-MeO-BDE47 and 2'-MeO-BDE68. A weak correlation only between BDE47 and its methoxylated analog 6-MeO-BDE47 was found and is indicative of a natural source for MeO-PBDEs.

Cetáceos en la Reserva Marina de las Islas Columbretes (Mediterráneo noroccidental): 20 años de avistamientos oportunistas

En el presente trabajo se recopilan veinte años de observaciones realizadas por los servicios de vigilancia de la Reserva Marina y Reserva Natural de las Islas Columbretes, así como aquellas notificadas por embarcaciones de recreo y pesca, desde la creación de la reserva en 1990. Las observaciones fueron realizadas durante todo el año en el interior de la Reserva Marina e inmediaciones. Por avistamiento se ha anotado la especie, el tamaño de grupo, hora y situación aproximada. Para cada especie se ha analizado la presencia a lo largo de los meses del año, la distancia a las islas y el tamaño de los grupos. Se han obtenido datos de un total de 366 observaciones y 4928 individuos. La especie más frecuente ha sido el delfín mular Tursiops truncatus con el 71 % de las observaciones totales, seguida por el rorcual común Balaenoptera physalus (20 %), delfín listado Stenella coeruleoalba (5 %), delfín común Delphinus delphis (1.4 %), y con porcentajes inferiores al 1%: calderón común Globicephala melas, calderón gris Grampus griseus, cachalote Physeter catodon y orca Orcinus orca. La presencia constante de delfín mular en la Reserva Marina durante estos 20 años es una evidencia de que la protección de estas aguas ha contribuido a la conservación de esta especie en la zona. Por otra parte, las observaciones de rorcual común al este de la Reserva Marina indican la existencia de una zona de paso de los individuos en su migración latitudinal.

Avistamiento de cetáceos en la Región de Murcia

En las aguas del golfo de Mazarrón se realizaron campañas para avistar cetáceos durante los años 1998, 1999, 2004, 2005, 2006, 2007 y 2008 a bordo de la goleta M/S Karyam, perteneciente a la empresa “Cetáceos y Navegación S.L.”. En todas las campañas de avistamiento las especies objetivo fueron las siguientes: Delfín mular (Tursiops truncatus), delfín listado, (Stenella coeruleoalba), delfín común (Delphinus delphis), calderón común (Globicephala melas), calderón gris (Grampus griseus), cachalote (Physeter macrocephalus), rorcual común (Balaenoptera physalus). Durante el periodo de muestreo se han realizado un total de 819 avistamientos con una estima aproximada de 21387 cetáceos, sin contar las salidas de avistamiento que aún se pueden hacer de octubre a diciembre del presente año. En los años comprendidos entre 2004 y 2008 las salidas de avistamientos exceden de las 100, repartidas entre los meses de marzo y diciembre, siendo la mayoría en los meses correspondientes a la estación de verano. En los años 1998 y 1999 se realizaron 31 y 67 días de campaña respectivamente, distribuidos prácticamente a lo largo de todo el año. Aún así se tienen en cuenta para establecer comparativas con años posteriores, ya que la diferencia en la abundancia de las especies avistadas es bastante notable. Con la información procedente de estas jornadas de avistamiento se realiza actualmente una caracterización de los cetáceos de las aguas de la Región de Murcia, en la que se detallan las características de cada una de las especies avistadas, una comparativa por años del número de individuos avistado por jornada, cantidad de grupos avistados por año, diversidad de especies por época del año y número de avistamiento por salida.

Concentrations of perfluorinated carboxylic acids (PFCAs) and sulfonic acids (PFSAs) in liver samples of different marine mammals (1984-2009)

Temporal variations in concentrations of perfluorinated carboxylic acids (PFCAs) and sulfonic acids (PFSAs), including perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) structural isomers, were examined in livers of pilot whale (Globicephala melas), ringed seal (Phoca hispida), minke whale (Balaenoptera acutorostrata), harbor porpoise (Phocoena phocoena), hooded seal (Cystophora cristata), Atlantic white-sided dolphin (Lagenorhynchus acutus) and in muscle tissue of fin whales (Balaenoptera physalus). The sampling spanned over 20 years (1984-2009) and covered a large geographical area of the North Atlantic and West Greenland. Liver and muscle samples were homogenized, extracted with acetonitrile, cleaned up using hexane and solid phase extraction (SPE), and analyzed by liquid chromatography with negative electrospray tandem mass spectrometry (LC-MS/MS). In general, the levels of the long-chained PFCAs (C9-C12) increased whereas the levels of PFOS remained steady over the studied period. The PFOS isomer pattern in pilot whale liver was relatively constant over the sampling years. However, in ringed seals there seemed to be a decrease in linear PFOS (L-PFOS) with time, going from 91% in 1984 to 83% in 2006.